179 related articles for article (PubMed ID: 6753245)
41. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
Tamulevicius P; Bamberg M; Scherer E; Streffer C
Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890
[TBL] [Abstract][Full Text] [Related]
42. Patterns of failure in intracranial astrocytomas after irradiation: analysis of dose and field factors.
Salazar OM; Rubin P; McDonald JV; Feldstein ML
AJR Am J Roentgenol; 1976 Feb; 126(2):279-92. PubMed ID: 175698
[TBL] [Abstract][Full Text] [Related]
43. [Supra-tentorial low-grade astrocytomas in adults. Prognostic factors and therapeutic indications. Apropos of a series of 141 patients].
Loiseau H; Bousquet P; Rivel J; Vital C; Kantor G; Rougier A; Dartigues JF; Cohadon F
Neurochirurgie; 1995; 41(1):38-50. PubMed ID: 7651570
[TBL] [Abstract][Full Text] [Related]
44. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
Deutsch M; Green SB; Strike TA; Burger PC; Robertson JT; Selker RG; Shapiro WR; Mealey J; Ransohoff J; Paoletti P
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1389-96. PubMed ID: 2542193
[TBL] [Abstract][Full Text] [Related]
45. Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers.
Magrini SM; Ricardi U; Santoni R; Krengli M; Lupattelli M; Cafaro I; Scoccianti S; Menichelli C; Bertoni F; Enrici RM; Tombolini V; Buglione M; Pirtoli L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):788-99. PubMed ID: 16682131
[TBL] [Abstract][Full Text] [Related]
46. Radiological and clinical outcome following stereotactic biopsy and radiotherapy for low-grade insular astrocytomas.
Shankar A; Rajshekhar V
Neurol India; 2003 Dec; 51(4):503-6. PubMed ID: 14742933
[TBL] [Abstract][Full Text] [Related]
47. [Local administration of radiosensitizer misonidazole].
Otsuka S; Suda K; Yamashita J; Gi H; Oda Y; Takeuchi J; Handa H; Ono K
No To Shinkei; 1983 Mar; 35(3):249-55. PubMed ID: 6687999
[No Abstract] [Full Text] [Related]
48. [Clinical trials of hypoxic cell sensitizer misonidazole].
Onoyama Y
Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
[TBL] [Abstract][Full Text] [Related]
49. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
Panis X; Nguyen TD; Froissart D; Demange L
Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760
[TBL] [Abstract][Full Text] [Related]
50. [Clinical evaluation of radiosensitizing effects of misonidazole].
Mitsuhashi N; Yonome I; Niibe H; Mogi K; Sakaino K; Nakajima N; Saito K; Suzuki Y; Sudo H; Okazaki A
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jul; 44(7):956-65. PubMed ID: 6514546
[No Abstract] [Full Text] [Related]
51. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
Van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
[TBL] [Abstract][Full Text] [Related]
52. Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.
Urtasun R; Feldstein ML; Partington J; Tanasichuk H; Miller JD; Russell DB; Agboola O; Mielke B
Br J Cancer; 1982 Jul; 46(1):101-8. PubMed ID: 6285947
[TBL] [Abstract][Full Text] [Related]
53. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC.
Ang KK; van der Schueren E; Notter G; Horiot JC; Chenal C; Fauchon F; Raps J; van Peperzeel H; Goffin JC; Vessière M; van Glabbeke M
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1657-64. PubMed ID: 6818185
[No Abstract] [Full Text] [Related]
54. New side effect of the hypoxic cell sensitizer, misonidazole.
Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
[TBL] [Abstract][Full Text] [Related]
55. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
[TBL] [Abstract][Full Text] [Related]
56. The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix.
Br J Radiol; 1984 Jun; 57(678):491-9. PubMed ID: 6372930
[TBL] [Abstract][Full Text] [Related]
57. Prognostic parameters in benign astrocytomas.
Westergaard L; Gjerris F; Klinken L
Acta Neurochir (Wien); 1993; 123(1-2):1-7. PubMed ID: 8213272
[TBL] [Abstract][Full Text] [Related]
58. Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
Ydrach AA; Marcial VA; Parsons J; Concannon J; Asbell SO; George F
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):357-9. PubMed ID: 6809704
[TBL] [Abstract][Full Text] [Related]
59. Clinical trials with hypoxic cell sensitizers-the European experience.
Dische S
Prog Clin Biol Res; 1983; 132D():293-303. PubMed ID: 6356146
[No Abstract] [Full Text] [Related]
60. [Clinical evaluation of misonidazole combined with radiotherapy in the treatment of carcinoma of the esophagus--a double-blind randomized trial].
Irie G; Sakurai T; Kikuchi Y; Watari T; Ikeda M; Mochizuki S; Kamata R; Kaneda K; Mikuriya S; Sakura M
Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2085-92. PubMed ID: 6397547
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
